Task: Answer the multiple choice question.
Query: Which drug exhibits a 8.586\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a. CC1CCCN(C(=O)CSCC(=O)N=c2sc3ccccc3n2C)C1
b. CCN(CC)C(=O)c1sc(NC(=O)Cc2ccccc2)c(C#N)c1C
Answer: a. CC1CCCN(C(=O)CSCC(=O)N=c2sc3ccccc3n2C)C1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC1CCCN(C(=O)CSCC(=O)N=c2sc3ccccc3n2C)C1
CC1CCCN(C(=O)CSCC(=O)N=c2sc3ccccc3n2C)C1
N-(3-methyl-1,3-benzothiazol-2-ylidene)-2-[2-(3-methylpiperidin-1-yl)-2-oxoethyl]sulfanylacetamide